Perioperative medicine & outcomes

Analysis of inappropriate prophylactic use of proton pump inhibitors during the perioperative period: an observational study

Perioper Med (Lond)Published Retrospective observational study

Authors' conclusion

The inappropriate prophylactic use of PPIs during the perioperative period is common.

Study context

Population
Inpatients who underwent surgery and received prophylactic proton pump inhibitors (PPIs), tertiary care academic teaching hospital in China, June–November 2022
Participants
472 inpatients
Outcome
Prevalence of inappropriate perioperative prophylactic use of PPIs (evaluated by clinical pharmacists)
Methodological detailssingle-centre, tertiary care academic teaching hospital
  • Single-centre
  • Tertiary care academic teaching hospital

Main finding

As reported in the abstract

At least one problem with inappropriate perioperative prophylactic PPI use

Patients with ≥1 inappropriate-use problem

131

27.75%

Drug use without indication

52.0%

Inappropriate usage and dosage

34.6%

Inappropriate duration of medication

6.7%

Observational data: associations, not effects.

Further findings

Factors associated with inappropriate prophylactic PPI use (multivariable logistic regression)

OR (95% CI)P value
Oral dosage form of PPIsMore inappropriate use18.301 (7.497–44.671)P < 0.001
Discharge medication of PPIsMore inappropriate use11.739 (1.289–106.886)P = 0.029
Junior doctorsMore inappropriate use9.167 (3.459–24.299)P < 0.001
AntithromboticsLess inappropriate use0.313 (0.136–0.721)P = 0.006
Postoperative hospital stay >15 daysLess inappropriate use0.262 (0.072–0.951)P = 0.042

Original publication

Analysis of inappropriate prophylactic use of proton pump inhibitors during the perioperative period: an observational study. Perioper Med (Lond). Published 14 March 2024. doi:10.1186/s13741-024-00376-w

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.